Enorama Pharma AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company is mainly focused on the development of medical chewing gum that contains drugs. The Company's product Nicotine gum is a chewing gum contained drugs that help to overcome nicotine addiction. In addition, the medical chewing gum applications include pain management, allergy, cough and cold, among others. The Company distributes its products in Europe through pharmacy chains and grocery stores.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-07	SEK 0.3390	+4.31%	2,111
26-08-06	SEK 0.3250	+5.52%	17,244
26-08-05	SEK 0.3080	-3.14%	76,461
26-08-04	SEK 0.3180	-0.63%	471
26-08-03	SEK 0.3200	+6.67%	24

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Delayed Nasdaq Stockholm Other stock markets 12:00:00 2026-08-07 EDT			5-day change	1st Jan Change
0.3390 ^SEK	+4.31%		+13.00%	-82.25%

06-16	Calendar Tuesday June 16	FW
06-15	Calendar Tuesday June 16	FW

Market Cap	25.29M 2.67M 2.31M 2.16M 1.98M 3.72M 254M 3.78M 9.92M 127M 10.02M 9.8M 421M	P/E 2024	-4.07x	P/E 2025	-1.77x
Enterprise Value	22.25M 2.35M 2.03M 1.9M 1.74M 3.27M 223M 3.32M 8.73M 112M 8.82M 8.62M 370M	EV / Sales 2024	12.8x	EV / Sales 2025	50.9x
Free-Float	6.43%	Yield 2024 *	-	Yield 2025	-

06-16	Calendar Tuesday June 16	FW
06-15	Calendar Tuesday June 16	FW
06-12	Calendar Monday June 15 - Friday June 19	FW
05-20	Enorama Pharma sells nicotine gum business assets to Aflofarm	RE
05-20	Enorama Pharma Q1 operating loss narrows to SEK 10.9 mln	RE
05-20	Enorama Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-20	Calendar Wednesday May 20	FW
05-19	Calendar Wednesday May 20	FW
04-23	Enorama Pharma AB Auditor Raises 'Going Concern' Doubt	CI
04-02	Financial Calendar: Monday April 6 - Friday April 10	FW
04-02	Financial Calendar: Friday April 3 - Tuesday April 7	FW
03-18	Enorama Pharma reports Q4 net sales of SEK 1.75 million	RE
03-18	Enorama Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

06-16	ENORAMA PHARMA: BULLETIN FROM THE ANNUAL GENERAL MEETING OF ENORAMA PHARMA AB (PUBL)	AQ
05-13	Notice of annual general meeting of Enorama Pharma AB (publ)	AQ
04-07	Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)	AQ
03-03	Enorama Pharma AB (publ) resolves to postpone the planned extraordinary general meeting	AQ
02-23	Bulletin from the extraordinary general meeting of Intellego Technologies AB (publ)	AQ

Enorama Pharma AB Stock

Stocks

ERMA

SE0008216329

Pharmaceuticals

Valuation: Enorama Pharma AB

Chart: Enorama Pharma AB

Latest news : Enorama Pharma AB

Press Releases: Enorama Pharma AB

Quotes and Performance

Course Extremes

Managers and Directors: Enorama Pharma AB

Latest insider transactions

Generic Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+4.31%
1 week	+13.00%
Current month	+13.00%
1 month	+27.44%
3 months	+27.92%
6 months	-77.32%
Current year	-82.25%

1 week	0.31	0.37
1 month	0.25	0.37
Current year	0.21	2.23
1 year	0.21	3
3 years	0.21	10.5
5 years	0.21	43.85
10 years	0.21	177

Manager	Title	Age	Since
Bengt Jönsson CEO	Chief Executive Officer	64	2025-11-10
Jonas Brisland DFI	Director of Finance/CFO	-	2025-08-31

Director	Title	Age	Since
Carl Olsson BRD	Director/Board Member	64	2022-12-31
Bengt Jönsson CHM	Chairman	64	2023-12-31
Tanu Tandan BRD	Director/Board Member	67	2023-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENORAMA PHARMA AB	+4.31%	+13.00%	-88.62%	-90.96%	2.67M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.03%	-0.97%	+20.89%	+69.03%	49.03B
OTSUKA HOLDINGS CO., LTD.	-1.14%	+9.22%	+59.57%	+124.81%	42.33B
CIPLA LIMITED	+0.27%	-0.45%	-2.47%	+16.58%	12.43B
ZYDUS LIFESCIENCES LIMITED	+0.43%	-0.18%	+17.11%	+70.10%	11.68B
KRKA, D. D.	+0.10%	+0.39%	+31.23%	+141.20%	9.12B
GEDEON RICHTER	+2.03%	+5.36%	+20.87%	+35.53%	7.15B
ONO PHARMACEUTICAL CO., LTD.	+1.62%	+3.49%	+40.44%	-13.45%	7.09B
GLENMARK PHARMACEUTICALS LIMITED	-1.22%	+0.96%	+9.86%	+177.80%	6.76B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+6.44%	+8.26%	-24.61%	+28.68%	5.95B
Average	+1.28%	+3.80%	+8.43%	+55.93%	15.15B
Weighted average by Cap.	+0.10%	+3.77%	+28.74%	+82.56%

	2024	2025
Net sales	15.77M 1.66M 1.44M 1.34M 1.23M 2.32M 158M 2.36M 6.19M 79.37M 6.25M 6.11M 262M	2.74M 289K 250K 233K 214K 403K 27.51M 409K 1.08M 13.79M 1.09M 1.06M 45.58M
Net income	-43.81M -4.62M -4M -3.73M -3.43M -6.44M -440M -6.54M -17.19M -220M -17.36M -16.98M -729M	-75.14M -7.93M -6.86M -6.4M -5.88M -11.05M -755M -11.23M -29.49M -378M -29.77M -29.12M -1.25B
Net Debt	-2.08M -220K -190K -178K -163K -307K -20.94M -311K -818K -10.49M -826K -808K -34.69M	-3.04M -320K -277K -259K -237K -447K -30.5M -454K -1.19M -15.29M -1.2M -1.18M -50.54M